191 related articles for article (PubMed ID: 11401970)
1. Antigenic diversity among Helicobacter pylori vacuolating toxins.
Vinion-Dubiel AD; McClain MS; Cao P; Mernaugh RL; Cover TL
Infect Immun; 2001 Jul; 69(7):4329-36. PubMed ID: 11401970
[TBL] [Abstract][Full Text] [Related]
2. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.
McClain MS; Cao P; Iwamoto H; Vinion-Dubiel AD; Szabo G; Shao Z; Cover TL
J Bacteriol; 2001 Nov; 183(22):6499-508. PubMed ID: 11673417
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-VacA antibody responses in serum and gastric juice samples using type s1/m1 and s2/m2 Helicobacter pylori VacA antigens.
Perez-Perez GI; Peek RM; Atherton JC; Blaser MJ; Cover TL
Clin Diagn Lab Immunol; 1999 Jul; 6(4):489-93. PubMed ID: 10391848
[TBL] [Abstract][Full Text] [Related]
4. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
Yamaguchi H; Osaki T; Taguchi H; Kamiya S
FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
[TBL] [Abstract][Full Text] [Related]
5. Potent neutralization of vacuolating cytotoxin (VacA) of Helicobacter pylori by immunoglobulins against the soluble recombinant VacA.
Ki MR; Hong IH; Park JK; Hong KS; Hwang OK; Han JY; Ji AR; Park SI; Lee SK; Yoo SE; Jeong KS
Anticancer Res; 2009 Jun; 29(6):2393-402. PubMed ID: 19528507
[TBL] [Abstract][Full Text] [Related]
6. Antigen epitope of Helicobacter pylori vacuolating cytotoxin A.
Liu XL; Li SQ; Liu CJ; Tao HX; Zhang ZS
World J Gastroenterol; 2004 Aug; 10(16):2340-3. PubMed ID: 15285016
[TBL] [Abstract][Full Text] [Related]
7. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin.
Cover TL; Krishna US; Israel DA; Peek RM
Cancer Res; 2003 Mar; 63(5):951-7. PubMed ID: 12615708
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies.
Manetti R; Massari P; Burroni D; de Bernard M; Marchini A; Olivieri R; Papini E; Montecucco C; Rappuoli R; Telford JL
Infect Immun; 1995 Nov; 63(11):4476-80. PubMed ID: 7591088
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on the variance of vacA genotypes and their vacuolating toxin activity of Helicobacter pylori isolates in Zhejiang area].
Chen XJ; Shen YF; Yan J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jul; 26(7):520-4. PubMed ID: 16335005
[TBL] [Abstract][Full Text] [Related]
10. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.
Caston RR; Sierra JC; Foegeding NJ; Truelock MD; Campbell AM; Frick-Cheng AE; Bimczok D; Wilson KT; McClain MS; Cover TL
Infect Immun; 2020 May; 88(6):. PubMed ID: 32284370
[No Abstract] [Full Text] [Related]
11. Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice.
Hong KS; Ki MR; Ullah HMA; Lee EJ; Kim YD; Chung MJ; Elfadl AK; Park JK; Jeong KS
Vaccine; 2018 Jan; 36(3):371-380. PubMed ID: 29223485
[TBL] [Abstract][Full Text] [Related]
12. Relation between vacA subtypes, cytotoxin activity, and disease in Helicobacter pylori-infected patients from The Netherlands.
Pan ZJ; van der Hulst RW; Tytgat GN; Dankert J; van der Ende A
Am J Gastroenterol; 1999 Jun; 94(6):1517-21. PubMed ID: 10364017
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori vacA genotypes and cagA gene in a series of 383 H. pylori-positive patients.
Rudi J; Kuck D; Rudy A; Sieg A; Maiwald M; Stremmel W
Z Gastroenterol; 2000 Jul; 38(7):559-64. PubMed ID: 10965552
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori.
Reyrat JM; Charrel M; Pagliaccia C; Burroni D; Lupetti P; de Bernard M; Ji X; Norais N; Papini E; Dallai R; Rappuoli R; Telford JL
FEMS Microbiol Lett; 1998 Aug; 165(1):79-84. PubMed ID: 9711842
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains.
Forsyth MH; Atherton JC; Blaser MJ; Cover TL
Infect Immun; 1998 Jul; 66(7):3088-94. PubMed ID: 9632570
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori genotypes and their association with host's immune response].
Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
[TBL] [Abstract][Full Text] [Related]
17. A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.
Vinion-Dubiel AD; McClain MS; Czajkowsky DM; Iwamoto H; Ye D; Cao P; Schraw W; Szabo G; Blanke SR; Shao Z; Cover TL
J Biol Chem; 1999 Dec; 274(53):37736-42. PubMed ID: 10608833
[TBL] [Abstract][Full Text] [Related]
18. Serological assays for identification of human gastric colonization by Helicobacter pylori strains expressing VacA m1 or m2.
Ghose C; Perez-Perez GI; Torres VJ; Crosatti M; Nomura A; Peek RM; Cover TL; Francois F; Blaser MJ
Clin Vaccine Immunol; 2007 Apr; 14(4):442-50. PubMed ID: 17267587
[TBL] [Abstract][Full Text] [Related]
19. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity.
Letley DP; Atherton JC
J Bacteriol; 2000 Jun; 182(11):3278-80. PubMed ID: 10809711
[TBL] [Abstract][Full Text] [Related]
20. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
Chen XJ; Yan J; Shen YF
Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
